Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy

NCT03176472 is registered in ClinicalTrials.gov with Regenacy Pharmaceuticals LLC as lead sponsor.

NCT NCT03176472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03176472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy
Lead sponsor
Regenacy Pharmaceuticals LLC
Phase
Phase 2
Overall status
Completed
Start date
December 7, 2020
Completion date
April 28, 2023
Enrollment
282 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

painful diabetic peripheral neuropathy